🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge
Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Adherence to and determinants of guideline‐recommended biomarker testing and targeted therapy in patients with gastroesophageal adenocarcinoma: Insights from routine practice

Cancer(2021)10.1002/cncr.33514Source: DataRank Database

Adherence to and determinants of guideline‐recommended biomarker testing and targeted therapy in patients with gastroesophageal adenocarcinoma: Insights from routine practice is a research paper published in Cancer (2021). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A
0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations
Download PDF
Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring
Enrichment:Funding (3 grants)Impact (FWCI 0.16)OA: bronzeTopics (36)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)
Findable (1/2)
  • Has DOI
Accessible (1/2)
  • Open Access
Interoperable (0/2)
    Reusable (0/3)

      FAIR checklist signals are shown for context only and do not affect DataRank scoring.

      Run a calibrated FAIR evaluation for this paper →

      We only score data papers we can read in full — never from an abstract alone.

      Authors (7)

      Yimei LiORCID,Jennifer R. EadsORCID,Xiaoliang WangORCID,Neal J. MeropolORCID,Ronac MamtaniORCID
      Live enrichment
      PubMed:33730386PMC:PMC8249344OpenAlex:https://openalex.org/W3137616772

      National Heart, Lung, and Blood Institute

      Grant: K01HL143153

      National Cancer Institute

      Grant: P30 CA016520

      National Cancer Institute

      Grant: T32 CA009679

      FWCI

      0.16

      Citation Percentile

      0.5%

      Citation Trend

      2022
      2023

      bronzeLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor
      journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.33514
      publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.33514
      publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.33514
      publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/cncr.33514
      publisherhttps://acsjournals.onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.33514

      Fields of Study

      HER2/EGFR in Cancer ResearchGastric Cancer Management and OutcomesEsophageal Cancer Research and TreatmentAdenocarcinomaAntineoplastic Combined Chemotherapy ProtocolsCross-Sectional StudiesHumansErb-b2 Receptor Tyrosine KinasesStomach NeoplasmsTrastuzumab

      MeSH Terms

      TrastuzumabAdenocarcinomaAntineoplastic Combined Chemotherapy ProtocolsCross-Sectional StudiesHumansStomach NeoplasmsReceptor, ErbB-2Erb-b2 Receptor Tyrosine Kinases

      Keywords

      MedicineTrastuzumabInternal medicineGuidelineCohortOncologyStage (stratigraphy)DiseaseCancerBiomarkerPathologyBreast cancerGastric cancerEsophageal cancerBiomarkersGuideline AdherenceMolecular Targeted TherapyPrecision Medicine